portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


 Lucid receives SFDA approval to market VivaScope Microscope in China
 
CreateTime:2008-03-26 Editor:liaoyan
Text Size:       
 
Lucid, a New York-based medical device and information company dedicated to providing improved care for dermatology patients announced that it has received the approval from China's State Food and Drug Administration to market Lucid VivaScope reflective confocal microscope in China. The sales of Lucid's VivaScope confocal microscopes in China will be handled by ConBio (China).
 
Lucid's VivaScope reflective confocal microscopes (RCM) provide non- invasive, in-vivo cellular resolution images of skin. Dermatologists can use the images to form a clinical judgment for a variety of skin conditions -- without the need for surgery to excise tissue -- thus improving the quality of care for their patients.
 
Mr Jay Eastman, CEO of Lucid, said, "Just as MRI and CT scans have largely eliminated the need for routine 'exploratory surgery', the use of Lucid's VivaScope confocal microscopes may one day eliminate the need for routine invasive skin biopsies. We believe that reflectance confocal microscopes will become a standard clinical tool with its capacity to take painless, non-invasive optical biopsies of a wide range of skin lesions and disorders."
 
He further said, "This milestone announcement opens opportunities for application of confocal microscopes to evaluate and monitor treatment of skin inflammatory and pigmentation disorders with leading hospitals throughout China. This positive outcome from a long and detailed review process that will allow us to participate in one of the fastest growing medical markets in the world."
 
Dr. Qiushi Ren, CEO, ConBio said, "We are excited by the opportunity to introduce Lucid's unique, leading RCM technology to Chinese doctors and building our business together."
 
Founded in 1996, ConBio is a multi-specialty health care company focused on providing innovative medical devices that enable people to live life to its greatest potential. ConBio has built strategic relationships with manufacturers in the dermatology, plastic and ophthalmologic fields around the world, including Lucid, Cutera, RA Medical, MedArt, Lutronic, Allergan, Schwind with a goal of becoming the leading provider of the advanced medical lasers, instruments and materials in China. ConBio has sold more than 1,000 units of capital equipment to customers in China.

Related Reports
China Independent Clinical Laboratory Industry Report, 2019-2025
Global and China Industrial Enzyme Industry Report, 2014-2017
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1